ArticleJournal for immunotherapy of cancer2025

Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma.

Daniela Esposito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.